Find More Contacts for Re-Vana Therapeutics
Protected Content
Non-Management
1 email found
View contacts for Re-Vana Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email info@re-vana.com
  • Phone Number l +44 28 9097 5814

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company focused on the development and commercialisation of innovative long-acting, biodegradable drug delivery platforms to address ophthalmic conditions such as age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and ocular infections.

Their delivery

platforms enable tailored delivery of therapeutics for long-term and can be administered by various routes to the eye. By using their platform technologies, delivery of a broad range of molecules including proteins, peptides, and small molecules can be achieved from 1 week to 1 year. The platform technologies are based on FDA-approved polymers.

Their injectable platform, OcuLief™, can be tailored for the treatment of AMD and DR to achieve a long-term release of anti-vascular endothelial growth factors (anti-VEGF) or corticosteroids for 1-12 months. Their preformed platform, EyeLief™, can be tailored for the treatment of Glaucoma and retina diseases, to achieve a long-term release of small or large molecules for 6 months or more.

The design strategy of Re-Vana revolves around increasing patient compliance by reducing pain and frequency of treatment, lowering side effects by controlled drug release, and cost saving for health care providers and pharmaceutical companies.

Lists Featuring This Company

United Kingdom Startups
8,891 Number of Organizations • $95.2B Total Funding Amount • 25,926 Number of Investors
Europe, Middle East, and Africa (EMEA) Therapeutics Companies
4,210 Number of Organizations • $36B Total Funding Amount • 3,294 Number of Investors
Market Research Companies with Early Stage Venture Funding
147 Number of Organizations • $2.4B Total Funding Amount • 734 Number of Investors
Therapeutics Companies With Less Than $50M in Revenue (Top 10K)
9,522 Number of Organizations • $164.9B Total Funding Amount • 11,414 Number of Investors

Frequently Asked Questions

Where is Re-Vana Therapeutics's headquarters? Re-Vana Therapeutics is located in Belfast, Belfast, United Kingdom.Who invested in Re-Vana Therapeutics? Re-Vana Therapeutics has 9 investors including Co-FundNI and QUBIS.How much funding has Re-Vana Therapeutics raised to date? Re-Vana Therapeutics has raised .When was the last funding round for Re-Vana Therapeutics? Re-Vana Therapeutics closed its last funding round on Nov 30, 2022 from a Series A round.Who are Re-Vana Therapeutics's competitors? Alternatives and possible competitors to Re-Vana Therapeutics may include Accent TherapeuticsSemma Therapeutics, and Calimmune.